Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company) the Company developing a new class of synthetic ...

Japan is the third-largest pharmaceutical market globally and accounts for approximately 5% of the total pharmaceutical sector. The country’s antibiotic resistance market is projected to reach ...

Primarily because most people like a good underdog story, and also because Nintendo has built a reputation for being very, ...

A new patent has been published in the US that sounds very similar to one of the Japanese patents which Pocketpair was ...

Enlivex Therapeutics Ltd. (ENLV) is making significant progress in immunotherapy with its innovative Allocetra™ technology.

Forward Medical, a leading innovator in plastic surgery, aesthetic surgery, and dermatology products, participated in the ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

In September of last year, and in light of a corresponding Japanese patent infringement suit, I published an article ...

A new patent has been published in the US that sounds very similar to one of the Japanese patents which Pocketpair was alleged to have infringed upon in Nintendo's ongoing lawsuit against the ...

Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent: Staten Island, New York Thursday, February 20, 2025, 18:00 Hrs [IST] Acurx Pharmaceuticals, Inc., ...